Brief: Orchid Pharma Gets No-Objection Letters From BSE, NSE For Merging Dhanuka Laboratories Into Co
03/09/2024 11:17
Sept 3 (Reuters) - Orchid Pharma Ltd ORCD.NS :
* GOT NO-OBJECTION LETTERS FROM BSE, NSE FOR MERGER OF
DHANUKA
LABORATORIES WITH CO
Further company coverage: ORCD.NS
((Reutersbriefs@thomsonreuters.com;))
Recent news on Orchid Pharma
See all newsBrief: Orchid Pharma Approves Enabling Resolution To Explore Fund Raising Via Equity Or Other Securities
Brief: Orchid Pharma To Consider And Evaluate Various Options For Raising Funds
Brief: Orchid Pharma June-Quarter Consol Profit 25.8 Million Rupees
India's Orchid Pharma jumps on pact to commercialize Exblifep in Russia
Refile: INDIA STOCKS-Indian shares set to open lower as US-Iran tensions lift oil prices